The short version
Just 3 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Atracurium Besylate
Atracurium Besylate · ATRACURIUM BESYLATE 10 mg/mL · Injection, Solution · Intravenous · Hospira, Inc.
NDC 00409-1105-02 · 10 VIAL, MULTI-DOSE in 1 CARTON / 10 mL in 1 VIAL, MULTI-DOSE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$140.69
Reported to Texas DSHS · 2026 annual filing · Pfizer Inc.
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- ANDA090761
- TE code
- AP
- Approval date
- Oct 18, 2012
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Atracurium Besylate (Injection, Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Hospira, Inc. | ATRACURIUM BESYLATE 10 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Meitheal Pharmaceuticals Inc. | ATRACURIUM BESYLATE 10 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| AuroMedics Pharma LLC | ATRACURIUM BESYLATE 100 mg/10mL | Jul 15, 2026 | Sep 2, 2026 |
| AuroMedics Pharma LLC | ATRACURIUM BESYLATE 50 mg/5mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Atracurium Besylate — NDC 00409-1105-02," retrieved September 3, 2026, https://drugdashboards.com/drug/00409110502.
Free to cite with attribution — see how the data is put together.